Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - calcium polystyrene, sulfonate - powder for oral suspension powder for rectal suspension - calcium polystyrene sulfonate 99.934 % (w/w) - all other therapeutic products

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - calcium (as carbonate); calcium (as lactate gluconate) - tablets effervescent - calcium (as lactate gluconate) 149.7 mg; calcium (as carbonate) 350.3 mg - calcium gluconate - oral calcium therapy.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - calcium as calcium chloride hexahydrate - oral solution/suspension - calcium as calcium chloride hexahydrate mineral-calcium-salt active 13305.0 mg/100ml - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - calcium supplement | parturient paresis | hypocalcaemia | milk fever

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - calcium as calcium glucoheptonate; calcium as calcium gluconate; boric acid - parenteral liquid/solution/suspension - calcium as calcium glucoheptonate carbohydrate active 0.82 g/100ml; calcium as calcium gluconate mineral-calcium-salt active 3.125 g/100ml; boric acid mineral-boron-acid other 8.2 g/100ml - nutrition & metabolism - cat | cattle | dog | goat | horse | pigs | sheep | beef | billy | bitch | boar | bos indicus | bos taurus | bovine | buck | buff - calcium supplement

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sykes vet (international) pty. ltd. - calcium as calcium carbonate, di-calcium phosphate and c; cobalt as cobalt (ii) sulfate; copper (cu) present as copper sulfate; iron as ferrous sulfate; magnesium as magnesium sulfate; manganese as manganese (ii) sulfate; zinc as zinc oxide; vitamin a; vitamin c = ascorbic acid; vitamin d3; vitamin e; vitamin k3 - oral powder, pre-mix - calcium as calcium carbonate, di-calcium phosphate and c mineral-calcium active 333.3 g/kg; cobalt as cobalt (ii) sulfate mineral-cobalt active 1.1 g/kg; copper (cu) present as copper sulfate mineral-copper active 1.2 g/kg; iron as ferrous sulfate mineral-iron active 3.7 g/kg; magnesium as magnesium sulfate mineral-magnesium active 17.6 g/kg; manganese as manganese (ii) sulfate mineral-manganese active 7.3 g/kg; zinc as zinc oxide mineral-zinc active 3.2 g/kg; vitamin a vitamin-a active 900000.0 iu/kg; vitamin c = ascorbic acid vitamin-c active 5390.0 mg/kg; vitamin d3 vitamin-d3 active 1200.0 mg/kg; vitamin e vitamin-e active 2600.0 iu/kg; vitamin k3 vitamin-k3 active 750.0 mg/kg - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - calcium supplement | iron deficiency | phosphorus deficiency | vitamin & mineral deficiency | anaemia

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - calcium chloride dihydrate 100 mg/ml; calcium chloride dihydrate 100 mg/ml - solution for injection - 1000 mg/10ml - active: calcium chloride dihydrate 100 mg/ml calcium chloride dihydrate 100 mg/ml excipient: hydrochloric acid sodium hydroxide water for injection - parenteral administration of calcium is indicated in the treatment of hypocalcaemia where a rapid increase in plasma calcium is required, such as in hypocalcaemic tetany and tetany due to parathyroid deficiency.

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium ; calcium carbonate; colecalciferol - granules effervescent - 35 + 1000/880 iu milligram - risedronic acid, calcium and colecalciferol, sequential

Ireland - English - HPRA (Health Products Regulatory Authority)

warner chilcott uk limited - risedronate sodium ; calcium carbonate ; colecalciferol concentrate (oily form) [vitamin d3] - granules effervescent - 35 & 1000/880 iu milligram - risedronic acid, calcium and colecalciferol, sequential

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - atorvastatin calcium trihydrate, quantity: 86.76 mg (equivalent: atorvastatin, qty 80 mg) - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; calcium carbonate; hyprolose; microcrystalline cellulose; polysorbate 80; croscarmellose sodium; titanium dioxide; macrogol 8000; hypromellose; purified talc; purified water; sodium chloride; dimeticone 100; benzoic acid; sorbic acid; methylcellulose; polysorbate 65; glyceryl distearate; silicon dioxide; dimeticonol; peg-4 stearate - as an adjunct to diet for the treatment of patients with hypercholesterolaemia. prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd), which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials, prevention of cardiovascular disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - atorvastatin calcium trihydrate, quantity: 43.38 mg (equivalent: atorvastatin, qty 40 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; polysorbate 80; croscarmellose sodium; magnesium stearate; hyprolose; candelilla wax; calcium carbonate; purified water; sodium chloride; dimeticone 100; benzoic acid; sorbic acid; methylcellulose; polysorbate 65; glyceryl distearate; silicon dioxide; dimeticonol; peg-4 stearate; titanium dioxide; macrogol 8000; hypromellose; purified talc - as an adjunct to diet for the treatment of patients with hypercholesterolaemia. prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd), which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials, prevention of cardiovascular disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.